Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are neurodegenerative diseases (NDD) characterized by progressive degeneration of the central nervous system, and few medications are available to halt the progression of AD and PD. In the present study, an engineered strain MG136-pMG36e-GLP-1 wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Xin, Zhou, Xiaoting, Miao, Yuqing, Han, Yiwen, Wei, Jing, Chen, Tingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182653/
https://www.ncbi.nlm.nih.gov/pubmed/32333225
http://dx.doi.org/10.1186/s13568-020-01014-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182653/
https://www.ncbi.nlm.nih.gov/pubmed/32333225
http://dx.doi.org/10.1186/s13568-020-01014-6

Ejemplares similares